Rafael Alberto Labriola is a distinguished inventor based in Buenos Aires, Argentina. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on zoledronic acid. With a total of 6 patents to his name, Labriola's research has advanced the understanding and application of this important compound.

Latest Patents

Labriola's latest patents focus on a new crystalline form of zoledronic acid. This innovative form is characterized by its X-ray diffractogram and spatial atomic distribution in the red crystalline state. His patents also detail the thermal analysis curves associated with this crystalline form. Additionally, Labriola has developed a method for obtaining this crystalline form, which includes the synthesis of the corresponding acid and the pharmaceutical composition that it comprises.

Career Highlights

Throughout his career, Labriola has worked with notable organizations, including Gador S.A. and the University of Leiden. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.

Collaborations

Some of Labriola's notable coworkers include Dora Graciela Tombari and Adriana Vechhioli. Their collaborative efforts have contributed to the advancements in pharmaceutical chemistry and the development of innovative solutions.

Conclusion

Rafael Alberto Labriola's work in the field of pharmaceutical chemistry, particularly with zoledronic acid, showcases his innovative spirit and dedication to advancing medical science. His contributions through patents and collaborations highlight the importance of research in developing new pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.